Related Experiment Video
Updated: Aug 28, 2025

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
Amphotericin B May Decrease the Serum Level of Voriconazole: A Case Report and Brief Review of Literature
1Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, People's Republic of China.
Combination therapy using amphotericin B (AmB) with voriconazole may reduce voriconazole serum levels. This interaction necessitates caution and further investigation before concurrent administration for invasive fungal infections.
Area of Science:
- Mycology
- Pharmacology
- Infectious Diseases
Background:
- Combination therapy of amphotericin B (AmB) and voriconazole is utilized to mitigate AmB-related adverse effects and enhance treatment outcomes.
- Limited data exist regarding the impact of AmB on voriconazole serum concentrations.
More Related Videos
Related Concept Videos
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Time Course of Drug Effect
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...

